EndoPAT is a non-invasive fingertip test of endothelial function: how well the inner lining of your blood vessels widens when it is asked to. It does not look for plaque, it does not image your arteries, and it cannot tell you whether an artery is narrowed.
It is a specialized test, used selectively. Its FDA clearance states that it is not intended as a screening test for the general population. At YoungerMeMD it is used when a provider thinks the result would add something, not as a routine part of every heart assessment.
Key takeaways
- EndoPAT is a non-invasive fingertip test of how well the lining of your blood vessels widens.
- It does not detect plaque or show whether an artery is narrowed.
- Its FDA clearance says it is not meant for screening the general population, and the clinic uses it selectively.
- Results can vary from one test to the next, so a small change may mean nothing.
- Basics such as blood pressure, ApoB, Lp(a), blood sugar and, where appropriate, a calcium score should come first.
What the endothelium is, and why it matters
The endothelium is the single layer of cells lining every blood vessel. One of its jobs is to release nitric oxide, a signal that tells the vessel to relax and widen when more blood flow is needed.
When that response is weak, it is called endothelial dysfunction. It is associated with most of the familiar risk factors, including smoking, diabetes, high cholesterol and excess weight, and it is thought to appear early in the process that leads to artery disease. It is a sign of how the vessel is behaving, which is different from how much arterial plaque is present.
How the test is done, and what the result is
You sit or lie still while a soft probe is placed on a fingertip of each hand. The probes sense the small pulse of blood volume in the finger with each heartbeat. This is called peripheral arterial tonometry, or PAT.
The test has three phases:
- Baseline. The probes record your resting pulse signal in both hands.
- Occlusion. A blood pressure cuff on one arm is inflated to stop blood flow to that hand for about five minutes. Your hand may tingle or feel numb. The other arm is left alone.
- Release. The cuff is deflated and blood rushes back. This surge is called reactive hyperemia. Healthy vessels respond by widening, and the pulse signal in the fingertip grows.
There are no needles and no radiation. The cuff phase is uncomfortable for some people but passes quickly once the cuff is released. To prepare, arrive fully fasted and have no caffeine beforehand.
The result is a number called the reactive hyperemia index, or RHI. It is a ratio: the size of the pulse signal after the cuff is released, compared with the signal before. The untested arm serves as a control, so that changes affecting your whole body during the test are taken out of the calculation.
A higher index means the vessels widened more. A lower index points to a weaker response. Some reports give the natural logarithm of the index instead.
We are deliberately not printing a cutoff here. Studies have used their own thresholds in their own patient groups, and no single number has been shown to separate healthy from unhealthy for everyone. Your result should be interpreted by the clinician who ordered it, alongside everything else known about you.
What the evidence shows
In a large community study, 1,957 adults in the Framingham Heart Study had the fingertip test. A weaker response went along with male sex, higher body mass index, a worse cholesterol ratio, diabetes and smoking.1
The study most often cited for prediction followed 270 outpatients at one center for about seven years. Those with a low index had more cardiac events: 48% against 28% in those with a higher index.2 A low index remained a predictor after other factors were taken into account.
A later meta-analysis pooled six studies of the fingertip method with 1,602 participants in total. It found that the result did predict cardiovascular events. It also found that the size of the effect varied considerably between studies, and it called for more research on whether guiding treatment by endothelial function improves outcomes.3
The limits you should know
- It does not detect plaque. A normal result does not mean your arteries are clear, and an abnormal result does not mean you have a blockage.
- It is not a screening test. The FDA clearance for EndoPAT says it is not intended for screening the general population.
- Results vary from one test to the next. In a small study that repeated the test 30 minutes apart in the same people, within-day variability was 18%, against 10% for the older ultrasound method of measuring endothelial function.4
- Its place in everyday care is not settled. A review in a leading cardiology journal concluded that the use of endothelial function testing as a clinical tool in daily medicine was not yet established, and that it remained to be shown that treating by the result leads to better outcomes.5
Because readings vary, a small change between two tests may be nothing more than normal variation.
Who it may be useful for
Since EndoPAT is not a screening tool, the question is whether it would add anything to what is already known about you. A provider might consider it when the standard picture leaves a gap: for example, when symptoms or history suggest a vessel-function problem that plaque imaging would not show. Erectile dysfunction is one situation in which vessel function comes up, because it can be an early vascular sign. See our page on erectile dysfunction.
It is less likely to help someone who has not yet had the basics done. Blood pressure, ApoB, Lp(a), blood sugar and, where appropriate, a calcium score all have stronger evidence and should come first.
EndoPAT and the Cardio Res-Q assessments
EndoPAT is done in our office and is used selectively, when indicated. It is an add-on that is not included in either entry assessment, and its price is not published. The Comprehensive Assessment ($775) covers Dr. Varano's clinical evaluation, advanced labs and a personalized heart protection plan. The Enhanced Assessment ($999) adds a CIMT ultrasound and a coronary calcium score.
If you think EndoPAT may apply to you, ask our team. Whether it is indicated is decided after your evaluation, not before it. To see the whole process, read what to expect at your assessment, or start on the Cardio Res-Q program page.
Are You a Candidate for Cardio Res-Q?
Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.
Frequently asked questions
Does EndoPAT show blocked arteries?
No. It measures how well small vessels in the fingertip widen after a brief interruption of blood flow. It does not image arteries and cannot find plaque or narrowing.
Is the EndoPAT test painful?
It is non-invasive, with no needles. The arm cuff stays inflated for about five minutes, which many people find uncomfortable, with tingling or numbness in the hand that clears when the cuff is released.
What is a good EndoPAT score?
A higher reactive hyperemia index reflects a stronger vessel response, but there is no universal cutoff that applies to everyone, and results vary between tests. Ask the clinician who ordered the test to explain your number and how the report defines its ranges.
Can I ask for EndoPAT instead of a calcium score?
They are not substitutes. A calcium score measures calcified plaque and has far more evidence behind it for predicting heart events. EndoPAT measures vessel function and is used selectively as an added test.
Related reading
This article is for general education and is not medical advice. Decisions about testing and medication should be made with your clinician. If you have chest pain or other symptoms of a heart attack, call 911.
